Amdocs EBITDA vs. Beta

DOX Stock  USD 86.13  1.02  1.20%   
Based on Amdocs' profitability indicators, Amdocs' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Amdocs' ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
1.1 B
Current Value
613.1 M
Quarterly Volatility
215.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Amdocs' Price To Sales Ratio is fairly stable compared to the past year. EV To Sales is likely to rise to 3.27 in 2024, whereas Days Sales Outstanding is likely to drop 58.54 in 2024. At this time, Amdocs' Interest Income is fairly stable compared to the past year. Change To Netincome is likely to rise to about 57.9 M in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (45.5 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.410.3535
Fairly Up
Pretty Stable
Net Profit Margin0.080.0996
Significantly Down
Pretty Stable
Operating Profit Margin0.150.1338
Moderately Up
Pretty Stable
Pretax Profit Margin0.110.12
Significantly Down
Pretty Stable
Return On Assets0.06260.0757
Significantly Down
Pretty Stable
Return On Equity0.06950.14
Way Down
Slightly volatile
For Amdocs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amdocs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amdocs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amdocs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amdocs over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Amdocs Beta vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth.
Amdocs is rated # 3 in ebitda category among related companies. It is rated below average in beta category among related companies . The ratio of EBITDA to Beta for Amdocs is about  1,326,501,441 . At this time, Amdocs' EBITDA is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Amdocs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amdocs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.

Amdocs Beta vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Amdocs

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
920.59 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Amdocs

Beta

 = 

Covariance

Variance

 = 
0.69
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Amdocs Beta Comparison

Amdocs is currently under evaluation in beta category among related companies.

Beta Analysis

As returns on the market increase, Amdocs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amdocs is expected to be smaller as well.

Amdocs Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Amdocs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amdocs will eventually generate negative long term returns. The profitability progress is the general direction of Amdocs' change in net profit over the period of time. It can combine multiple indicators of Amdocs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-47.9 M-45.5 M
Operating Income752.1 M403.8 M
Income Before Tax731.8 M423 M
Total Other Income Expense Net-81.5 M-77.5 M
Net Income624.4 M350.6 M
Income Tax Expense107.4 M72.5 M
Net Income Applicable To Common Shares631.9 M396.4 M
Net Income From Continuing Ops624.4 M531 M
Interest Income24.4 M25.7 M
Net Interest Income-15.9 M-15.1 M
Change To Netincome55.1 M57.9 M
Net Income Per Share 4.14  4.34 
Income Quality 1.36  1.43 
Net Income Per E B T 0.76  0.58 

Amdocs Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Amdocs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amdocs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amdocs' important profitability drivers and their relationship over time.

Use Amdocs in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Amdocs Pair Trading

Amdocs Pair Trading Analysis

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Amdocs position

In addition to having Amdocs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Online Gaming Thematic Idea Now

Online Gaming
Online Gaming Theme
Companies that are involved in the building and marketing of online gaming-related products. The Online Gaming theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Online Gaming Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
To fully project Amdocs' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Amdocs at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Amdocs' income statement, its balance sheet, and the statement of cash flows.
Potential Amdocs investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Amdocs investors may work on each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.